Diamond Biotechnology Co., Ltd (TPEX:6815)
Taiwan · Delayed Price · Currency is TWD 25.60
0.00 (0.00%)
Jul 30, 2026, 1:45 PM CST
Diamond Biotechnology Market Cap
Diamond Biotechnology has a market cap or net worth of 1.02 billion as of July 29, 2026. Its market cap has decreased by -42.71% in one year.
Market Cap
1.02B
Enterprise Value
1.04B
Revenue
501.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.60
ChartMarket Cap Chart
Since January 29, 2021, Diamond Biotechnology's market cap has decreased from 1.68B to 1.02B, a decrease of -39.52%. That is a compound annual growth rate of -8.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 1.02B | -59.40% |
| Dec 31, 2025 | 2.50B | -7.50% |
| Dec 31, 2024 | 2.71B | 12.05% |
| Dec 29, 2023 | 2.42B | 179.34% |
| Dec 30, 2022 | 864.86M | -11.33% |
| Dec 30, 2021 | 975.37M | -41.97% |
| Jan 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taiwan Biomaterial | 1.59B |
| Bioptik Technology Incorporation | 1.33B |
| AViTA | 1.18B |
| NaviFUS | 1.13B |
| Rossmax International | 1.08B |
| S&S Healthcare Holding | 1.01B |
| Wiltrom | 971.75M |
| Cowealth Medical Holding | 921.70M |